Form 4 for DGX Quest Diagnostics
Accepted 2022-07-05 00:00:00 ET · period of report 2022-07-01 · accession 0001022079-22-000112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-05 | 2022-07-01 | DGX | RING TIMOTHY M | Dir | M - OptEx | $57.46 | +2,000 | 24.9K | +9% | +$114.9K |
| D | 2022-07-05 | 2022-07-01 | DGX | RING TIMOTHY M | Dir | S - Sale+OE | $133.47 | -2,000 | 23.9K | -8% | -$266.9K |
| D | 2022-07-05 | 2022-07-01 | DGX | RING TIMOTHY M | Dir | A - Grant | $134.74 | +308 | 12.4K | +3% | +$41.5K |
| DM | 2022-07-05 | 2022-07-01 | DGX | RING TIMOTHY M | Dir | M - OptEx | $57.46 | -2,000 | 0 | -100% | -$114.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | M | A | 990 | $58.69 | 25,933 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-01 | M | A | 1,010 | $56.25 | 24,943 | D | — | — | |
| 3 | Common | Common Stock | 2022-07-01 | S | D | 2,000 | $133.47 | 23,933 | D | — | — | |
| 4 | Derivative | Phantom Stock Units | 2022-07-01 | A | A | 308 | $134.74 | 12,355.27 | D | $0.00 · — to — | 308 Common Stock | (F3) Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. (F2) Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. |
| 5 | Derivative | Stock Options (Right to Buy) | 2022-07-01 | M | D | 1,010 | $56.25 | 149 | D | $56.25 · 2013-04-01 to 2023-04-01 | 1,010 Common Stock | |
| 6 | Derivative | Stock Options (Right to Buy) | 2022-07-01 | M | D | 990 | $58.69 | 0 | D | $58.69 · 2013-01-02 to 2023-01-02 | 990 Common Stock |